Filing metadata

Accession number
0000929638-23-000831
Form type
Form 3
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Mar 13, 2023
Reporting period
Mar 03, 2023
Description
Initial ownership

Explore SEC Filings Hub